|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2010-6-4
|
|
pubmed:abstractText |
Reactivity against terminal NeuNAc(alpha2-3)Gal, common to several gangliosides such as GD1a, GT1b and GM3, has rarely been reported. The authors recently described a patient with a clinical picture of acute relapsing sensory ataxic neuropathy and bulbar involvement in whom they demonstrated concomitant reactivity against NeuNAc(alpha2-3)Gal and disialosyl epitopes. The authors suggested a correlation between NeuNAc(alpha2-3)Gal reactivity and bulbar involvement.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1468-330X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
81
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
623-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19726412-Antibody Specificity,
pubmed-meshheading:19726412-Bulbar Palsy, Progressive,
pubmed-meshheading:19726412-Female,
pubmed-meshheading:19726412-G(M3) Ganglioside,
pubmed-meshheading:19726412-Gangliosides,
pubmed-meshheading:19726412-Humans,
pubmed-meshheading:19726412-Immunoglobulin G,
pubmed-meshheading:19726412-Immunoglobulin M,
pubmed-meshheading:19726412-Male,
pubmed-meshheading:19726412-Middle Aged,
pubmed-meshheading:19726412-Retrospective Studies
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Bulbar involvement in patients with antiganglioside antibodies against NeuNAc(alpha2-3)Gal.
|
|
pubmed:affiliation |
Department of Neurology, Neuromuscular Diseases Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. rrojas@santpau.cat
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
